Filtros de búsqueda

Lista de obras de Akihiro Yoshimura

A Phase II Study of S-1 and Paclitaxel Combination Therapy as a First-Line Treatment in Elderly Patients with Advanced Non-Small Cell Lung Cancer

artículo científico publicado en 2018

AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells

artículo científico publicado en 2019

An observational study of the epidermal growth factor receptor-tyrosine kinase inhibitor resistance mechanism in epidermal growth factor receptor gene mutation-positive non-small cell lung cancer

article

Association of Sarcopenia with and Efficacy of Anti-PD-1/PD-L1 Therapy in Non-Small-Cell Lung Cancer.

artículo científico publicado en 2019

BK virus pneumonia following stem cell transplantation against diffuse large B‐cell lymphoma.

artículo científico publicado en 2018

Carcinoembryonic antigen and CYFRA 21-1 responses as prognostic factors in advanced non-small cell lung cancer

scientific article published on 01 June 2019

Clinical Characteristics of Osimertinib Responder in Non-Small Cell Lung Cancer Patients with EGFR-T790M Mutation

artículo científico publicado en 2019

Comparing three different anti-PD-L1 antibodies for immunohistochemical evaluation of small cell lung cancer

artículo científico publicado en 2019

Impact of bowel movement condition on immune checkpoint inhibitor efficacy in patients with advanced non-small cell lung cancer

artículo científico publicado en 2019

ONO-7475, a Novel AXL Inhibitor, Suppresses the Adaptive Resistance to Initial EGFR-TKI Treatment in EGFR-Mutated Non-Small Lung Cancer

artículo científico publicado en 2020

Phase II Study of S-1 and Paclitaxel Combination Therapy in Patients with Previously Treated Non-Small Cell Lung Cancer

scientific article published on 30 April 2019

Prognostic impact of pleural effusion in EGFR-mutant non-small cell lung cancer patients without brain metastasis

artículo científico publicado en 2019

Pulmonary pleomorphic carcinoma with pseudoprogression during nivolumab therapy and the usefulness of tumor markers: A case report.

artículo científico publicado en 2018

Retrospective efficacy analysis of immune checkpoint inhibitors in patients with EGFR-mutated non-small cell lung cancer

scientific article published on 21 February 2019

Safety and Usefulness of Cryobiopsy and Stamp Cytology for the Diagnosis of Peripheral Pulmonary Lesions

artículo científico publicado en 2019

The impact of the tumor shrinkage by initial EGFR inhibitors according to the detection of EGFR-T790M mutation in patients with non-small cell lung cancer harboring EGFR mutations

artículo científico publicado en 2018

Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer

artículo científico publicado en 2020

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda